Arcadia Biosciences, Inc. (NASDAQ:RKDA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On November 10, 2016, Darby Shupp voluntarily resigned from the Board of Directors of Arcadia Biosciences, Inc. (the “Company”), effective immediately. There were no disagreements between Ms. Shupp and the Company or any officer or director of the Company that led to Ms. Shupp’s resignation. With the resignation, Ms. Shupp also resigned from her role as chairman of the Board of Directors and as chair of the Nominating and Governance Committee.
The Board intends to begin a search for an additional director. George Gosbee has been appointed as Interim Chairman of the Board, and has stepped down as chair of the Audit Committee. Kevin Comcowich has been appointed to serve as chair of the Audit Committee.
About Arcadia Biosciences, Inc. (NASDAQ:RKDA)
